0

The Scripps Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 17-May-2017
No. of pages: 135

Summary

The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institute offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. It also offers undergraduate, graduate and postdoctoral programs. TSRI also organizes academic preparation and educational outreach programs. The institute operates through its research centers and institutes including Integrative Molecular Biosciences, Center for Metabolomics, Dorris Neuroscience Center, Molecular Screening Center, and others. TSRI is headquartered in La Jolla, California, the US.

The Scripps Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 11
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deal Details 15
Partnerships 15
Pfizer Enters into Licensing Agreement with Scripps Research Institute 15
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 15
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 16
Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 17
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 18
Scripps Research Institute, ZIP and IME Enter into Partnership 19
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 20
Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 21
Scripps Research Institute Expands Research Agreement With Takeda 22
Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 23
Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 24
ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 25
Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 26
LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 26
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 27
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 28
Licensing Agreements 29
Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 29
BlinkBio Enters into Option agreement with Scripps Research Institute 30
iGenomX Enters into Licensing Agreement with Scripps Research Institute 31
OPKO Health Enters into Licensing Agreement with Scripps Research Institute 31
Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 32
Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 33
Fabrus Enters into Licensing Agreement with Scripps Research Institute 34
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 35
Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 36
Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 37
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 38
Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 39
Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 40
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 41
OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 41
Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 42
Equity Offering 43
Blackthorn Therapeutics Spin Off from Scripps Research Institute 43
The Scripps Research Institute - Key Competitors 45
Key Employees 46
Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 48
Corporate Communications 48
Jun 01, 2016: TSRI Appoints Richard King as Chief Operating Officer 48
Government and Public Interest 49
May 04, 2017: Scientists Solve Major Cancer Protein Conundrum 49
Mar 27, 2017: Scientists discover new class of anti-diabetes compounds that reduce liver glucose production 50
Feb 14, 2017: Scripps Florida Collaboration Awarded $3.3 Million to Develop Next-Generation Breast Cancer Therapies 51
Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 52
Jan 30, 2017: New TSRI Study Shows Early Brain Changes in Fragile X Syndrome 54
Jan 24, 2017: Scripps Florida team awarded $1.8 million grant to develop drugs for heart disease and rheumatoid arthritis 55
Dec 29, 2016: Scripps Florida scientists uncover new way to defeat therapy-resistant prostate cancer 56
Dec 22, 2016: TSRI study: Protein monitors lung volume and regulates breathing 57
Dec 12, 2016: Study shows aging process increases DNA mutations in important type of stem cell 59
Dec 07, 2016: Scripps Florida Scientists Uncover Potential Driver of Age- and Alzheimer's-Related Memory Loss 60
Oct 17, 2016: Scripps Florida Scientists Uncover New Facets of Zika-Related Birth Defects to Help Develop Treatment 61
Oct 13, 2016: Scripps Florida Scientists Awarded Special Grant to Develop Memory-Altering Medication for Addiction 62
Oct 12, 2016: Scientists Identify Potent New Anti-Obesity, Anti-Diabetes Target 63
Oct 05, 2016: Grant to TSRI-Led Consortium Expands to $207 Million 64
Sep 12, 2016: TSRI scientists discover antibodies that target holes in HIV's defenses 65
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 66
Sep 01, 2016: New TSRI Method Makes Building ‘One-Handed' Drugs Easier than Ever 68
Aug 11, 2016: New Study Shines Light on Mutations Responsible for Debilitating Heart Conditions 70
Aug 02, 2016: TSRI Researchers Find ‘Lead Actors' in Immune Cell Development 71
Aug 01, 2016: A Potential New Way to Sway the Immune System 73
Jul 20, 2016: TSRI team finds potential drug candidates that could intervene in deadly diseases 74
Jul 07, 2016: Walgreens to Participate in U.S. Precision Medicine Initiative Cohort Program through The Scripps Research Institute 76
Jul 06, 2016: NIH awards $55 million to build million-person precision medicine study 77
Jun 28, 2016: TSRI scientists stabilize HIV structure, design potential AIDS vaccine candidates 79
Jun 27, 2016: TSRI scientists find new cancer drug target in dual-function protein 81
Jun 23, 2016: TSRI Scientists Reveal Single-Neuron Gene Landscape of the Human Brain 82
Jun 15, 2016: New TSRI Method Opens Door to Development of Many New Medicines 83
Jun 07, 2016: Scripps Florida Scientists Awarded $1.3 Million to Optimize Chemical Probes to Test an Innovative Approach to Cancer Treatment 85
May 26, 2016: TSRI Scientists Discover Mechanism that Turns Mutant Cells into Aggressive Cancers 86
May 09, 2016: Scripps Florida scientists pioneer a breakthrough approach to breast cancer treatment 87
Apr 27, 2016: TSRI, Harvard, Stanford and Brandeis Collaborate to Study MicroRNA's Role in Memory, Sleep and Synapse Function 88
Apr 21, 2016: New Molecule-Building Method from TSRI Opens Up Vast Realm of Chemistry for Pharma and Other Industries 89
Apr 14, 2016: Scripps Florida Study Identifies Memory Suppressor Gene That Could Hold Key to New Alzheimer's Disease Treatments 91
Apr 05, 2016: TSRI scientists get first-ever glimpse of 'teenage' HIV-neutralizing antibody 92
Apr 04, 2016: TSRI Scientists: Immune Cell Transforms from ‘Clark Kent' to 'Superman' 94
Mar 31, 2016: Scripps Florida Team Awarded $3.4M to Develop Treatments for Addiction, Mood Disorders 95
Mar 28, 2016: TSRI, Salk Scientists Discover 'Outlier' Enzymes that Could Offer New Targets to Treat Diabetes, Inflammation 96
Mar 18, 2016: Scripps Florida Scientists Win $1.4 Million Grant to Develop New Ways to Block Breast Cancer 98
Mar 10, 2016: TSRI study identifies new type of protein clump that may be implicated in ALS 99
Mar 09, 2016: Scripps Florida study lays groundwork for potential bipolar disorder therapies 100
Mar 08, 2016: Scripps Florida Scientists Win $2.4 Million to Develop New Strategies to Fight Obesity 101
Feb 29, 2016: Scripps Florida Scientists Find Way to Predict Activity of Stem Cells 102
Feb 24, 2016: Scripps Florida Scientists Awarded $2.25 Million to Study Key Mechanisms Behind Some Cancers 103
Feb 19, 2016: TSRI and JCVI scientists find popular stem cell techniques safe 104
Feb 18, 2016: Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor 105
Feb 16, 2016: TSRI Scientists Create Vaccine Against Dangerous Designer Opioids 107
Feb 12, 2016: Scripps Florida Scientists Win $1.7 Million Grant to Advance New Strategies to Treat Huntington's Disease 108
Feb 11, 2016: Scripps Florida scientists identify a memory suppressor that may play a role in autism 109
Feb 03, 2016: Scripps Florida Scientists Win $1.2 Million to Study New Strategies for Treating Obesity, Diabetes, Cardiovascular Disease and Muscle Decline 110
Jan 27, 2016: Philanthropist Samuel Yin Provides $12.8 Million Gift for New Laboratories at The Scripps Research Institute 111
Jan 25, 2016: Crouching Protein, Hidden Enzyme : The Scripps Research Institute 112
Jan 14, 2016: TSRI Researchers Develop Versatile New Way to Build Molecules 114
Jan 12, 2016: TSRI Chemists Awarded $2.1 Million to Create Potential New Therapies with Click Chemistry 116
Product News 117
Dec 29, 2016: Scripps Florida scientists develop drug discovery approach to predict health impact of endocrine-disruptors 117
Dec 20, 2016: Scripps Florida scientists discover new natural source of potent anti-cancer drugs 119
Dec 12, 2016: TSRI scientists devise new approaches to personalized medicines 120
Nov 21, 2016: Scripps Florida Scientists Create Innovative Drug Design Strategy to Improve Breast Cancer Treatment 121
May 19, 2016: New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design 122
Mar 31, 2016: TSRI-Calibr Team Creates Novel Platform for Generating Long-Acting Drug Candidates 123
Mar 28, 2016: A Novel Peptide Engineering Platform for Generating Stapled Long-acting Peptide Hormones 124
Mar 24, 2016: New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial 125
Mar 23, 2016: TSRI Chemists Find a Way to Synthesize Complex Plant Molecule Phorbol and Its Derivatives 126
03/16/2017: Scripps Florida scientists develop new drug delivery method for cancer therapy 128
Mar 09, 2017: Potential drug candidates halt prostate and breast cancer growth 129
Jan 28, 2016: TSRI Study Reveals Workings of Mysterious 'Relief Valve' that Protects Cells from Swelling 130
Jan 14, 2016: TSRI Chemists Devise Powerful New Method for Modifying Drug Molecules 132
Jan 14, 2016: California Institute for Biomedical Research releases a pair of research articles describing a novel switchable CAR-T cell platform to treat cancer 134
Appendix 135
Methodology 135
About GlobalData 135
Contact Us 135
Disclaimer 135

List of Tables
The Scripps Research Institute, Pharmaceuticals & Healthcare, Key Facts 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Scripps Research Institute, Deals By Therapy Area, 2011 to YTD 2017 10
The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 11
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Pfizer Enters into Licensing Agreement with Scripps Research Institute 15
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 15
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 16
Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 17
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 18
Scripps Research Institute, ZIP and IME Enter into Partnership 19
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 20
Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 21
Scripps Research Institute Expands Research Agreement With Takeda 22
Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 23
Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 24
ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 25
Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 26
LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 26
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 27
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 28
Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 29
BlinkBio Enters into Option agreement with Scripps Research Institute 30
iGenomX Enters into Licensing Agreement with Scripps Research Institute 31
OPKO Health Enters into Licensing Agreement with Scripps Research Institute 31
Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 32
Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 33
Fabrus Enters into Licensing Agreement with Scripps Research Institute 34
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 35
Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 36
Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 37
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 38
Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 39
Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 40
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 41
OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 41
Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 42
Blackthorn Therapeutics Spin Off from Scripps Research Institute 43
The Scripps Research Institute, Key Competitors 45
The Scripps Research Institute, Key Employees 46
The Scripps Research Institute, Other Locations 47
The Scripps Research Institute, Subsidiaries 47

List of Figures
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 11

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2021 RnR Company Profiles. All rights reserved.